Our Blog

The Effects of Consumer Marketing on U.S. Testosterone Usage

According to a study published online January 1 in the Journal of Clinical Endocrinology & Metabolism, the usage of testosterone-boosting supplements nearly quadrupled in the U.S. between 2001 and 2010, while the usage of these drugs increased by only 30% in the United Kingdom during the same time period.

One big difference is the prevalence of direct-to-consumer marketing of branded pharmaceuticals in the United States. Such ads are prohibited in the United Kingdom,” said testosterone lawyer Ken Rothweiler.

Because of misleading ads in the U.S., more men may think they need ‘Low T’ drugs to help combat declines in sexual drive, energy and athleticism. But in reality, the FDA has approved testosterone therapies for men with low levels of testosterone and an associated medical condition,” Rothweiler added.

For the retrospective study, researchers evaluated commercial and Medicare insurance claims from the United States and United Kingdom general practitioner records between 2000 and 2011.

According to a January 10 Medscape article on their findings, about 36% of U.S. men with low testosterone levels began taking hormone-enhancing therapies in 2007, with that percentage rising to 43% by 2011. In the United Kingdom, about 10% of men found to have low testosterone levels started these therapies, and that rate remained constant from 2000 to 2011.

This contrast shows why American physicians should re-examine how they are prescribing these drugs and really weigh the potential health risks for each patient,” said Rothweiler.

According to a separate study published in January in the journal PLOS One, testosterone-boosting therapies doubled the risk of heart attacks in men over age 65 and tripled this risk in younger men with pre-existing heart conditions.

Testosterone drugs are supposed to help the men who are prescribed them, and instead they often put their health and well-being at risk,” Rothweiler said.

Ken Rothweiler is part of a legal team comprised of him, Alex MacDonald and Jon Ostroff. Together, the Rothweiler, MacDonald, and Ostroff led team is providing legal representation for those who are eligible to file a testosterone lawsuit from the side effects of their testosterone therapy.


This is a unique website which will require a more modern browser to work! Please upgrade today!